封面
市場調查報告書
商品編碼
1700295

蛋白質結晶市場報告:趨勢、預測和競爭分析(至 2031 年)

Protein Crystallization Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球蛋白質結晶市場前景光明,在製藥和生物技術市場以及學術研究市場都存在機會。預計到 2031 年全球蛋白質結晶市場規模將達到 18 億美元,2025 年至 2031 年的複合年成長率為 8.5%。該市場的主要驅動力是對基於蛋白質的療法的興趣日益濃厚以及蛋白質結晶技術的進步。

  • Lucintel 表示,根據產品類型,預計預測期內消耗品仍將是最大的細分市場。
  • 根據最終用途,預計製藥和生物技術在預測期內仍將是最大的細分市場。
  • 按地區分類,預測期內北美將繼續成為最大的地區。

蛋白質結晶市場的策略性成長機會

由於技術發展需要更多的結構數據,蛋白質結晶市場正經歷新的策略性成長機會。這些應用涉及各個市場,包括與結構生物學數位產品相關的藥物發現;

  • 藥物研發:對於參與藥物發現的研究人員來說,藥物代表著巨大的未開發潛力,需要結晶提供的詳細結構資訊。到目前為止,用於正確確定蛋白質結構的結晶技術已經取得了很大進步,這對於開發新型治療藥物至關重要。
  • 結構生物學:結構生物學是一個關鍵的發展領域,它致力於更清楚地了解蛋白質結構及其功能。結晶透過提供有助於研究複雜生物過程的重要資訊發揮至關重要的作用。
  • 生物技術產業:蛋白質結晶用於生物技術產業,以推進新型生物製藥的研究和開發。還有潛力開發新的結晶技術和方法來支持生物技術產業的藥物發現和蛋白質工程。
  • 學術研究:透過資助和合作計劃,學術機構正在擴大其蛋白質結晶能力。這些機會包括開發培訓計劃的新方法以改善研究成果。
  • 醫學診斷:醫學診斷越來越依賴蛋白質結晶來提高診斷測試的準確性並開發新的診斷工具。結晶技術在該領域的應用將進一步實現與疾病相關的蛋白質的檢測和表徵。

此類成長策略將擴大應用範圍,並最終推動塑造蛋白質結晶市場的技術發展。在支持藥物研究、結構生物學、生物技術、學術界和醫學診斷方面,整體市場格局正在改變。

蛋白質結晶市場促進因素與挑戰

蛋白質結晶市場受到幾個主要促進因素和挑戰的影響,包括技術創新、經濟條件和法律方面。這些因素將影響蛋白質結晶技術和應用的擴展。

推動蛋白質結晶市場發展的因素有:

1. 技術進步:成像技術和自動化系統的進步正在推動蛋白質結晶市場的發展。新方法將提高蛋白質結構測定的準確性,加速藥物發現和結構生物學研究。

2.增加研究經費:政府/私部門的資金增加將促進蛋白質結晶的發展。增加投資將促進新技術/方法的產生,並透過擴大研究能力來刺激創新。

3. 藥物研發需求不斷成長:對新藥,尤其是標靶治療的需求不斷成長,刺激了對蛋白質結晶的需求。生產有效的藥物需要準確的蛋白質結構數據,這開啟了新的市場前景。

4.生技產業的成長:生技產業的擴張是蛋白質結晶市場的主要促進因素。結晶技術正在幫助生物技術公司透過蛋白質工程方法來推進藥物開發並獲得更多市場機會。

5. 合作研究計畫:透過研究機構、生技公司和製藥公司的合作,蛋白質結晶技術正在不斷進步。這種夥伴關係可以實現知識共用和資源分配,從而加速該領域的進步。

蛋白質結晶市場面臨的挑戰包括:

1. 設備和技術高成本:先進設備/結晶技術高成本可能會阻礙進一步的市場進入。小型實驗室和生技公司可能無法負擔這些費用,從而阻礙他們的研究活動。

2. 蛋白質結晶的複雜性:蛋白質結晶非常複雜,有多種因素會影響結果。如果無法獲得高品質的結晶,將會阻礙研究進展和市場發展。

3. 監管和合規問題:蛋白質結晶市場公司面臨監管要求和合規問題。了解這些法規並遵守既定標準需要知識、時間和金錢,這會影響市場動態。

目錄

第1章執行摘要

第2章全球蛋白質結晶市場:市場動態

  • 簡介、背景和分類
  • 供應鏈
  • 產業驅動力與挑戰

第3章市場趨勢與預測分析(2019-2031)

  • 宏觀經濟趨勢(2019-2024)及預測(2025-2031)
  • 全球蛋白質結晶市場趨勢(2019-2024)及預測(2025-2031)
  • 全球蛋白質結晶市場類型
    • 裝置
    • 耗材
    • 軟體與服務
  • 全球蛋白質結晶市場(按技術)
    • X光結晶結構分析
    • 低溫電子顯微鏡
    • 核磁共振波譜
    • 其他
  • 全球蛋白質結晶市場(按最終用途)
    • 製藥和生物技術
    • 學術研究所
    • 其他

第4章區域市場趨勢與預測分析(2019-2031)

  • 全球蛋白質結晶市場(按地區)
  • 北美蛋白質結晶市場
  • 歐洲蛋白質結晶市場
  • 亞太蛋白質結晶市場
  • 世界其他地區蛋白質結晶市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球蛋白質結晶市場成長機會(按類型)
    • 全球蛋白質結晶市場成長機會(按技術)
    • 全球蛋白質結晶市場成長機會(依最終用途分類)
    • 全球蛋白質結晶市場各區域成長機會
  • 全球蛋白質結晶市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球蛋白質結晶市場的產能
    • 全球蛋白質結晶市場的企業合併
    • 認證和許可

第7章主要企業簡介

  • Rigaku
  • FORMULATRIX
  • METTLER TOLEDO
  • Corning
  • Greiner Bio-One International
  • HAMPTON RESEARCH
  • Jena Bioscience
  • Bruker
  • Creative Proteomics
  • Molecular Dimensions
簡介目錄

The future of the global protein crystallization market looks promising with opportunities in the pharmaceutical & biotechnology and academic & research institute markets. The global protein crystallization market is expected to reach an estimated $1.8 billion by 2031 with a CAGR of 8.5% from 2025 to 2031. The major drivers for this market are the growing interest in protein-based therapeutics and advancements in technology related to protein crystallography techniques.

  • Lucintel forecasts that, within the product type category, consumables will remain the largest segment over the forecast period.
  • Within the end-use category, pharmaceutical & biotechnology will remain the larger segment over the forecast period.
  • In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Protein Crystallization Market

Emerging trends in the protein crystallization industry involve integrating advanced technologies and methodologies for improved efficiency and accuracy of protein structure determination. Reliance on these trends is important as it drives drug discovery, structural biology, and therapeutic development.

  • Integration of AI and Machine Learning: AI has transformed protein crystallization by enabling the prediction of conditions under which proteins can crystallize, optimizing experiments accordingly. This trend enhances the speed at which protein structures are determined, making it easier for researchers to engage in drug discovery and structural biology research.
  • Advancements in High-Throughput Screening: High-throughput screening processes have become more sophisticated, allowing researchers to test a wide range of conditions quickly. This improves the efficiency of crystallography experiments and speeds up the process of finding new protein structures.
  • Development of New Crystallization Techniques: Alternative crystallization methods, such as microfluidic devices or vapor diffusion approaches, are being developed for difficult proteins. These approaches enhance quality and reproducibility, delivering better structural data and insights.
  • Automation and Robotics: Automation is becoming more prevalent in protein crystallization, eliminating human errors. Automated monitoring and analysis systems now increase reproducibility and efficiency in protein crystallization workflows by providing faster operations.
  • Focus on Structural Biology and Drug Discovery: There is increasing emphasis on protein crystallization for structural biology and drug discovery. The goal is to understand protein structures to develop targeted therapies and new drugs, driving innovation in the field.

These emerging trends have restructured the protein crystallization market by improving the efficiency, accuracy, and speed of protein structure determination. This has led to major strides in drug discovery and structural biology through the integration of advanced technologies and methodologies.

Recent Developments in the Protein Crystallization Market

Some recent advances noted within the protein crystallization market signify significant progress made in technology and methodology. These innovations will result in more accurate protein structure determinations at a higher efficient level, hence impacting drug discovery and leading to new therapeutics.

  • Advanced Techniques For Imaging : Protein structure determination is being improved by using advanced imaging techniques like high resolution X-ray or cryo electron microscopy. Such methods provide detailed information of a given protein's shape thus helps to know its purpose for targeted therapy development efforts.
  • Automating Processes During Crystallization: Automated systems for protein crystallization are becoming more popular resulting in streamlining experimental workflows and increased throughput. In this way, automation reduces human intervention errors while ensuring that the quality of resultant crystals is maintained at a very high level.
  • New Ways of Crystallizing Proteins : There have been developments such as microfluidic techniques or improved vapor diffusion protocols targeting at new crystallization methods. This enhances crystal quality, makes it possible to achieve accurate structural analysis for molecules through discovering novel drugs out of them.
  • Increased Funding For Research: Research on protein crystallization has gained momentum over time due to increased funding from both the government and private sectors. All this financial assistance is being directed to developing new innovations in crystallization technology as well as extending research capabilities within structural biology.
  • Cooperation and Partnerships: Collaborations between research institutions, biotech companies and pharmaceutical firms have been instrumental for advancement of protein crystallization. This is made possible through partnerships that enhance sharing of knowledge, resources and technologies thereby accelerating progress within this industry.

Rapid changes are taking place in the protein crystallization market about efficiency and accuracy in determining the protein structures. New advancements are transforming drug discovery and structural biology.

Strategic Growth Opportunities for Protein Crystallization Market

There are emerging strategic growth opportunities in the protein crystallization market resulting from technological developments that demand more structural data. These applications cut across different markets including drug discovery among others related to structural biology digital products.

  • Pharmaceutical Research and Development: For researchers involved in drug discovery, pharmaceuticals offer huge untapped potential where detailed information about structure is required via crystallography. So far, significant improvements have been made concerning advancing crystallizing techniques used for proper determination of proteins' structures which are vital towards development of novel therapeutics.
  • Structural Biology: An important growth area is structural biology where efforts are focused on understanding protein structures and their functions more explicitly. Crystallography plays an essential role by providing critical information that helps us study complex biological processes while pioneering new research tools along these lines.
  • Biotech Industry: Protein crystallization is being used by the biotech industry to drive research and development of new biopharmaceuticals. Also, there is potential to develop novel technologies for crystallization and methods to support drug discovery and protein engineering in the biotechnology industry.
  • Academic Research: Funding and collaborative projects have led academic institutions to expand their protein crystallization capabilities. These opportunities also encompass the development of new methodologies for training programs for improved research outputs.
  • Medical Diagnostics: Medical diagnostics are now becoming reliant on protein crystallography to improve the accuracy of diagnostic tests or even create new diagnostic tools. The use of crystallization techniques in this area can further enable detection as well as characterization of disease-related proteins.

These growth strategies expand applications which result into technological developments that shape the protein crystallization market. The overall market landscape is evolving with a view to supporting pharmaceutical research, structural biology, biotech, academia, and medical diagnostics.

Protein Crystallization Market Driver and Challenges

The protein crystallization market is affected by several prime drivers and challenges such as technological revolutions, economic terms, and legal aspects. These components influence the progression of protein crystallography technologies and applications.

The factors responsible for driving the protein crystallization market include:

1. Technological Advancements: Advancements in imaging techniques and automated systems are driving the protein crystallization market. New methods enhance the accuracy of protein structure determination speeding up drug discovery as well as structural biology research

2. Increased Research Funding: More funding from government/private sectors drives protein crystallization forward. Investment increases lead to building new technologies/methodologies that stimulate innovation through extended research capabilities.

3. Increased Demand for Drug Discovery: Growing need for new drugs especially targeted therapies is spurring protein crystallization demand. For effective medication production it needs accurate protein structure data thereby opening market prospects.

4. Growth in Biotech Industry: The biotech industry's expansion forms a major driver for the protein crystallization market. By using crystalline techniques, biotech firms drive drug development ahead besides contributing towards the growth of this market via protein engineering approaches.

5. Collaborative Research Initiatives: Protein crystallography is making progress due to collaboration between research institutions, biotechnology companies as well as pharmaceutical organizations. These alliances enable sharing knowledge & allocating resources thus speeding up field's advancement.

Challenges in the protein crystallization market are:

1. High Costs of Equipment and Technology: High costs for advanced equipment/crystallography technology could block entry into further markets: small-scale laboratories or biotechnology firms may be unable to afford them thus impeding their research activities.

2. Complexity of Protein Crystallization: Protein crystallography is highly complicated with multiple factors that can impact on its outcome. The failure to obtain quality crystals hampers research progress and market development.

3. Regulatory and Compliance Issues: Protein crystallization Market Companies face regulatory requirements and compliance issues. These regulations require knowledge on navigating them and adherence to set standards which may be time-consuming as well as costly thus affecting the market dynamics.

The drivers and challenges in the protein crystallization market drive its growth. Key drivers are technology, funding, drug discovery while complexity, high costs, regulation etc. present difficulties. Consequently, understanding these aspects is highly necessary for one to explore markets and make the most of opportunities available.

List of Protein Crystallization Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies protein crystallization companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the protein crystallization companies profiled in this report include-

  • Rigaku
  • FORMULATRIX
  • METTLER TOLEDO
  • Corning
  • Greiner Bio-One International
  • HAMPTON RESEARCH
  • Jena Bioscience
  • Bruker
  • Creative Proteomics
  • Molecular Dimensions

Protein Crystallization by Segment

The study includes a forecast for the global protein crystallization market by product type, technology, end use, and region.

Protein Crystallization Market by Product Type [Analysis by Value from 2019 to 2031]:

  • Instruments
  • Consumables
  • Software & Services

Protein Crystallization Market by Technology [Analysis by Value from 2019 to 2031]:

  • X-Ray Crystallography
  • Cryo-Electron Microscopy
  • NMR Spectroscopy
  • Others

Protein Crystallization Market by End Use [Analysis by Value from 2019 to 2031]:

  • Pharmaceutical & Biotechnology
  • Academic & Research Institutes
  • Others

Protein Crystallization Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Protein Crystallization Market

The protein crystallization industry has seen major advancements due to technology and increasing applications in the pharmaceutical and research sectors. Significant developments in the United States, China, Germany, India, and Japan emphasize the global expansion of protein crystallization techniques, aiding drug discovery, structural biology, and therapeutic development.

  • United States: There is a merging of advanced imaging with protein crystallization. High-resolution X-ray at facilities is increasingly coupled with cryo-electron microscopy for more accurate understanding of protein structures. Automation investment and high-throughput screening technologies are speeding up drug discovery, driven by leading pharmaceutical firms.
  • China: The Chinese market has rapidly improved its protein crystallization capabilities with a focus on novel crystal growth methods and automated systems. Biotech companies and research institutions leverage these advances to improve protein structure determination, supported by government funding for biotech research.
  • Germany: Germany focuses on improving crystallization protocols and optimizing conditions for difficult proteins. New approaches enhance the reproducibility and quality of protein crystals at research centers, with an emphasis on collaboration with international partners.
  • India: Several state-of-the-art facilities have been set up in Indian research institutes to cater to modern protein crystallization needs. The country is also investing in training programs and receiving government support, boosting growth in biotech start-ups.
  • Japan: Artificial intelligence is being integrated into Japanese protein crystallization methods, making the country a leader in using AI for predicting crystallization conditions and optimizing structures. Japanese companies are also developing new equipment and techniques to further improve the precision of structural biology.

Features of the Global Protein Crystallization Market

Market Size Estimates: Protein crystallization market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Protein crystallization market size by product type, technology, end use, and region in terms of value ($B).

Regional Analysis: Protein crystallization market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, end uses, and regions for the protein crystallization market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the protein crystallization market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the protein crystallization market by product type (instruments, consumables, and software & services), technology (x-ray crystallography, cryo-electron microscopy, NMR spectroscopy, and others), end use (pharmaceutical & biotechnology, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Protein Crystallization Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Protein Crystallization Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Protein Crystallization Market by Product Type
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Software & Services
  • 3.4: Global Protein Crystallization Market by Technology
    • 3.4.1: X-Ray Crystallography
    • 3.4.2: Cryo-Electron Microscopy
    • 3.4.3: NMR Spectroscopy
    • 3.4.4: Others
  • 3.5: Global Protein Crystallization Market by End Use
    • 3.5.1: Pharmaceutical & Biotechnology
    • 3.5.2: Academic & Research Institutes
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Protein Crystallization Market by Region
  • 4.2: North American Protein Crystallization Market
    • 4.2.1: North American Market by Product Type: Instruments, Consumables, and Software & Services
    • 4.2.2: North American Market by End Use: Pharmaceutical & Biotechnology, Academic & Research Institutes, and Others
  • 4.3: European Protein Crystallization Market
    • 4.3.1: European Market by Product Type: Instruments, Consumables, and Software & Services
    • 4.3.2: European Market by End Use: Pharmaceutical & Biotechnology, Academic & Research Institutes, and Others
  • 4.4: APAC Protein Crystallization Market
    • 4.4.1: APAC Market by Product Type: Instruments, Consumables, and Software & Services
    • 4.4.2: APAC Market by End Use: Pharmaceutical & Biotechnology, Academic & Research Institutes, and Others
  • 4.5: ROW Protein Crystallization Market
    • 4.5.1: ROW Market by Product Type: Instruments, Consumables, and Software & Services
    • 4.5.2: ROW Market by End Use: Pharmaceutical & Biotechnology, Academic & Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Protein Crystallization Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Protein Crystallization Market by Technology
    • 6.1.3: Growth Opportunities for the Global Protein Crystallization Market by End Use
    • 6.1.4: Growth Opportunities for the Global Protein Crystallization Market by Region
  • 6.2: Emerging Trends in the Global Protein Crystallization Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Protein Crystallization Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Protein Crystallization Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Rigaku
  • 7.2: FORMULATRIX
  • 7.3: METTLER TOLEDO
  • 7.4: Corning
  • 7.5: Greiner Bio-One International
  • 7.6: HAMPTON RESEARCH
  • 7.7: Jena Bioscience
  • 7.8: Bruker
  • 7.9: Creative Proteomics
  • 7.10: Molecular Dimensions